The NOMAN is an Island: Race to End HPV Campaign is joining forces with Jo’s Cervical Cancer Trust to launch and co-chair a new HPV Coalition.
The HPV Coalition, established in 2022, is an expert advisory group of leading patient groups, professional groups, clinicians, and expert individuals who have come together to inform and advance the UK’s journey towards elimination of HPV-related cancers – cancers which account for 5% of all cancers globally, and which we now, for the first time in history, have the opportunity to eliminate as a public health threat.
Despite the scale of the opportunity, the UK has yet to take the step of other countries, such as Australia and Canada, in developing an action plan for cervical cancer elimination. The UK also lags behind the European Union which, through the Beating Cancer Plan, has gone one step further, in committing to eliminate all HPV cancers. The HPV Coalition is therefore eager to see the UK put in place a concrete plan for elimination as a matter of priority, targeted at the whole range of HPV-related cancers and supporting access to preventative interventions for all parts of the population.
We recognise that concerted and collaborative action is essential to success, and therefore the HPV Coalition is committed to working in close and positive partnership with parliamentarians and policymakers in support of elimination ambitions, ensuring that the UK’s current opportunity to lead the world in HPV elimination is not missed. For further information on HPV Coalition activity please contact the secretariat – provided by Incisive Health – at HPVCoalition@incisivehealth.com.
HPV Coalition members:
Co-Chair: Samantha Dixon, Chief Executive, Jo’s Cervical Cancer Trust
Co-Chair: David Winterflood, Chief Executive, NOMAN Campaign
Peter Baker, Director, Global Action on Men’s Health and formerly Campaign Director HPV Action
Dr Jake Bayley, Consultant in sexual health and Chair, HPV Special Interest Group, British Association for Sexual Health and HIV
Dr Nigel Carter, Chief Executive, Oral Health Foundation
Professor Emma Crosbie, Professor of Gynaecological Oncology
Dr Kate Cuschieri, Director of Human Papillomavirus Research Group & Scottish HPV Reference Laboratory, University of Edinburgh
Dr Anne Connolly, Chair, Primary Care Women’s Health Forum
Robert Cornes, Male Cancer Information Nurse Specialist, ORCHID Penile Cancer
Dr Jennifer Davies-Oliveira, Clinical Research Fellow Gynaecology-Oncology, University of Manchester
Helen Donovan, Immunisation and Vaccination Specialist Nurse
Anita Harris, Director of Clinical Operations, Brook
Melvyn Hill, Chief Executive, UK Cervical Cancer
Catrin Hughes, Faculty of Sexual and Reproductive Healthcare
Vas James, Head of Programmes, The Eve Appeal
Lorna Kelly, Faculty of Sexual and Reproductive Healthcare
Tamara Kahn, Chief Executive, Oracle Cancer Trust
Athena Lamnisos, Chief Executive, The Eve Appeal
Hilary Maxwell, CEO and Chair, GO Girls
Dr Fernanda Perez, Policy and Public Affairs Executive, Royal Society of Public Health
Dr Gillian Prue, Reader in Chronic Illness, Queen’s University Belfast
Heather Randle, Professional Lead for Education and Primary Care, Royal College of Nursing
Professor Peter Sasieni, Professor of Cancer Prevention, King’s College of London
Dr Sue Sherman, Reader in Psychology, Keele University
Ceri Smith, Head of Policy and Parliamentary Affairs, Terence Higgins Trust
Martin Tod, Chief Executive, Men’s Health Forum
Professor Martin Widschwendter, Professor in Women's Cancer, University College London
Support for the HPV Coalition is provided by BD UK Ltd, Hologic UK Ltd, MSD UK Ltd, and Roche Diagnostics UK Ltd , who fund HPV Coalition meetings, activities, and the HPV Coalition secretariat, delivered by Incisive Health. Corporate supporters have no influence or input in the selection or content of HPV Coalition projects or communications. Members of the HPV Coalition receive no payment for their involvement in the group, except to cover appropriate travel costs for attending meetings. For further information on our please find the HPV Coalition’s Terms of Reference below.